News & Analysis on Clinical Trial Services & Contract Research And Development
Its upcoming inhalable insulin drug may prove a blockbuster but Nektar's 2005 results brought the biopharmaceutical company further in the red, with a net loss of $108.2m (€91m) in Q4 more than five times higher than the $19.3m loss it posted in Q4 of...
A new laboratory method for distinguishing pathogens from harmless relatives has been developed by scientists in the US. The high-throughput technique will enable the quick identification of pathogens, which could be used for bioterror weapons.
Swiss custom manufacturing firm Lonza has entered into a joint venture with investment management company Bio*One Capital to built a $250m (€210m) large-scale mammalian cell culture plant in Singapore, underlying Lonza's confidence that demand for the...
Warwick Analytical Services has made available a service that allows the investigation and measurement of the optical activity of samples with an accuracy of +/- 0.002 degrees for optical rotations of less than 1 degree.
Finnish packaging company Stora Enso and pharmaceutical group Orion are carrying out a trial of pharmaceuticals packages equipped with RFID (Radio Frequency Identification) tags for every stage of the supply chain using a system that defies the...
Chemical manufacturing giant BASF is building an alkylethanolamine (AEOA) plant at its US site in Louisiana, as increasing American demand pushes the company to increase worldwide production capacities for these important intermediates by 40 per cent.